Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.31B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$339M |
| 3 |
Tesla
TSLA
|
+$275M |
| 4 |
Alibaba
BABA
|
+$236M |
| 5 |
AGN
Allergan plc
AGN
|
+$214M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$474M |
| 2 |
Gilead Sciences
GILD
|
+$359M |
| 3 |
Amazon
AMZN
|
+$274M |
| 4 |
Intel
INTC
|
+$248M |
| 5 |
Microsoft
MSFT
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.94% |
| 2 | Technology | 2.38% |
| 3 | Consumer Discretionary | 1.42% |
| 4 | Communication Services | 1.04% |
| 5 | Healthcare | 0.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STON
3926
DELISTED
StoneMor Inc.
STON
| $1.96M | ﹤0.01% |
300,214
+174,781
| +139% | +$1.21M |
|
3927
Dr. Reddy's Laboratories
RDY
$10.1B
| $1.95M | ﹤0.01% |
+273,805
| New | +$1.97M |
|
3928
PUT
TE Connectivity
TEL
$58.7B
| $1.95M | ﹤0.01% |
23,500
+500
| +2% | +$40.2K |
|
3929
CALL
Kearny Financial
KRNY
$638M
| $1.95M | ﹤0.01% |
127,000
-31,200
| -20% | -$454K |
|
3930
PUT
Vanguard Health Care ETF
VHT
$19.3B
| $1.95M | ﹤0.01% |
12,800
-1,000
| -7% | -$149K |
|
3931
CALL
Wabash National
WNC
$543M
| $1.95M | ﹤0.01% |
85,300
+68,100
| +396% | +$1.43M |
|
3932
Direxion NASDAQ-100 Equal Weighted Index ETF
QQQE
$1.44B
| $1.95M | ﹤0.01% |
+46,997
| New | +$1.91M |
|
3933
Selective Insurance
SIGI
$5.51B
| $1.95M | ﹤0.01% |
36,143
-4,425
| -11% | -$225K |
|
|
TCP
3934
PUT
DELISTED
TC Pipelines LP
TCP
| $1.95M | ﹤0.01% |
37,200
+25,100
| +207% | +$1.35M |
|
3935
ProShares Ultra Russell2000
UWM
$248M
| $1.94M | ﹤0.01% |
58,196
-111,104
| -66% | -$3.35M |
|
3936
ICU Medical
ICUI
$4.38B
| $1.94M | ﹤0.01% |
10,455
-6,831
| -40% | -$1.19M |
|
|
HIFR
3937
DELISTED
InfraREIT, Inc.
HIFR
| $1.94M | ﹤0.01% |
86,890
-54,139
| -38% | -$1.16M |
|
|
FDC
3938
CALL
DELISTED
First Data Corporation
FDC
| $1.94M | ﹤0.01% |
107,700
-452,100
| -81% | -$8.25M |
|
3939
CALL
SLM Corp
SLM
$4.97B
| $1.94M | ﹤0.01% |
169,200
-54,100
| -24% | -$587K |
|
|
TGNA
3940
PUT
DELISTED
TEGNA Inc
TGNA
| $1.94M | ﹤0.01% |
145,500
-45,100
| -24% | -$605K |
|
|
APRN
3941
PUT
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
| $1.94M | ﹤0.01% |
+1,978
| New | +$2.17M |
|
|
AMRN
3942
CALL
Amarin Corp
AMRN
$295M
| $1.94M | ﹤0.01% |
27,700
-13,905
| -33% | -$985K |
|
|
KERX
3943
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $1.94M | ﹤0.01% |
272,906
+37,198
| +16% | +$267K |
|
3944
PUT
Banco Bradesco
BBD
$34.4B
| $1.93M | ﹤0.01% |
306,758
-110,669
| -27% | -$643K |
|
3945
CALL
Watsco Inc
WSO
$12.8B
| $1.93M | ﹤0.01% |
12,000
+3,300
| +38% | +$499K |
|
|
CVSA
3946
PUT
Covista Inc
CVSA
$4.58B
| $1.93M | ﹤0.01% |
53,900
+38,700
| +255% | +$1.32M |
|
|
EFOR
3947
Everforth Inc
EFOR
$1.31B
| $1.93M | ﹤0.01% |
35,973
-15,589
| -30% | -$780K |
|
3948
Vanguard Long-Term Treasury ETF
VGLT
$10.4B
| $1.93M | ﹤0.01% |
25,107
-24,828
| -50% | -$1.92M |
|
3949
Aurinia Pharmaceuticals
AUPH
$2.17B
| $1.93M | ﹤0.01% |
307,676
+52,043
| +20% | +$328K |
|
|
ESL
3950
PUT
DELISTED
Esterline Technologies
ESL
| $1.93M | ﹤0.01% |
21,400
+15,900
| +289% | +$1.43M |
|
Similar funds
Jeff Yass's Q3 2017 Portfolio in Review
As of Q3 2017, Jeff Yass held 10,422 positions worth $259B, up 14% from $228B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jeff Yass's Q3 2017 filing shows 1,312 new, 3,605 increased, 3,645 reduced and 1,693 closed positions. Its largest new stake was JPMorgan Chase: 794,224 shares worth $75.9M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $474M.
By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, up from 91% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q3 2017 buy was JPMorgan Chase: 794,224 shares worth $75.9M.
- Jeff Yass added most to Apple in Q3 2017, an estimated $1.31B increase.
- Jeff Yass's biggest Q3 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $474M.
- Jeff Yass fully exited iShares 20+ Year Treasury Bond ETF in Q3 2017, selling an estimated $69.3M.
- Jeff Yass's ten largest holdings make up 24% of its $259B portfolio in Q3 2017.
- Jeff Yass opened 1,312 new positions and closed 1,693 in Q3 2017.
- Jeff Yass's portfolio value rose 14% quarter-over-quarter to $259B.
Based on Susquehanna International Group's 13F filing for Q3 2017, filed 14 Nov 2017.